EMICIZUMAB FOR THE TREATMENT OF INFANTS WITH SEVERE HEMOPHILIA A: INTERIM ANALYSIS OF HAVEN 7

被引：0

作者：

Pipe, Steven ^{[1
]}

Collins, Peter ^{[1
]}

Dhalluin, Christophe ^{[1
]}

Kenet, Gili ^{[1
]}

Schmitt, Christophe ^{[1
]}

Buri, Muriel ^{[1
]}

Jimenez-Yuste, Victor ^{[1
]}

Peyvandi, Flora ^{[1
]}

Young, Guy ^{[1
]}

Oldenburg, Johannes ^{[1
]}

ElisaMancuso, Maria ^{[1
]}

Kiialainen, Anna ^{[1
]}

Chang, Tiffany ^{[1
]}

Lehle, Michaela ^{[1
]}

Fijnvandraat, Karin ^{[1
]}

机构：

[1] Childrens Hosp Los Angeles, Los Angeles, CA USA

来源：

PEDIATRIC BLOOD & CANCER | 2023年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2011

引用

页码：S7 / S7

页数：1

共 50 条

[31] Assessment of the impact of pharmaceutical consultations at initiation of a treatment with emicizumab in patients with severe hemophilia A without inhibitors
Allah, M. Nasr
Pieragostini, R.
Oka, G.
Batista, R.
Stieltjes, N.
Lopez, I.
ANNALES PHARMACEUTIQUES FRANCAISES, 2022, 80 (06): : 915 - 922
[32] Multicenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A
Josset, Laurie
Leuci, Alexandre
Janbain, Maissaa
De-Wreede, Anaelle
Desage, Stephanie
Lienhart, Anne
Bin, Valerie
Lebert, Dorothee
Delavenne, Xavier
Dargaud, Yesim
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 22 (07) : 1857 - 1866
[33] First report of emicizumab use in a female patient with severe hemophilia A
Verstraete, Geraldine
Lambert, Catherine
Hermans, Cedric
BLOOD ADVANCES, 2020, 4 (13) : 2950 - 2952
[34] Immunogenicity of Emicizumab in People with Hemophilia A (PwHA): Results from the HAVEN 1-4 Studies
Paz-Priel, Ido
Chang, Tiffany
Asikanius, Elina
Chebon, Sammy
Emrich, Thomas
Fernandez, Elena
Kuebler, Peter
Schmitt, Christophe
BLOOD, 2018, 132
[35] Inhibitory Body Hemophilia A HAVEN-I Study demonstrates Efficacy of Bleeding Prophylaxis with Emicizumab
不详
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 (02) : 118 - 118
[36] Present Status of Infants with Hemophilia A Treated with Emicizumab: A Single Center Cohort
Mori, Mika
Nagae, Chiai
Kim, Yufa
Umezawa, Yotaro
Ashikaga, Tomoko
Yamashita, Atsuki
Mori, Tetsuya
Taki, Masashi
PEDIATRIC BLOOD & CANCER, 2020, 67
[37] ISTH Congress: Early Prophylaxis in Infants and Young Children with Hemophilia A with Emicizumab
Reisdorf, Simone
TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (05)
[38] Traumatic Tonsillar Hemorrhage during Hemophilia A Treatment with Emicizumab
Inoue, Fumiya
Terada, Kazuki
Furudate, Kazuki
Noguchi, Yasushi
Igarashi, Shunji
HEMATOLOGY REPORTS, 2022, 14 (02) : 108 - 111
[39] Emicizumab and Females with Hemophilia A: Case Series from ATHN 7
Recht, Michael
Daoud, Nabil
Lee, Lucy
Morton, Paul
Raffini, Leslie J.
BLOOD, 2022, 140 : 2745 - 2746
[40] Real-world case series and summary of current literature of infants and toddlers with severe hemophilia A with inhibitor on prophylaxis with emicizumab
Garcia, Jessica
Zia, Ayesha
PEDIATRIC BLOOD & CANCER, 2021, 68 (05)

← 1 2 3 4 5 →